Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

Shire Acquires Lumena Pharmaceuticals

May 12, 2014

Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.

Boehringer Ingelheim and Connexios Life Sciences Enter Agreement for AMPK Activators

May 9, 2014

Boehringer Ingelheim and Connexios Life Sciences announce global research collaboration agreement for AMPK agonists.

NIH Study Reveals New Cancer Immunotherapy Method

May 9, 2014

Scientists at the National Cancer Institute found a new cancer immunotherapy method that could be effective against a wide range of cancers.

Cumberland Pharmaceuticals and Gloria Pharmaceuticals Announce R&D Investment

May 9, 2014

Cumberland Pharmaceuticals and Gloria Pharmaceuticals invest $1 million each in Cumberland Emerging Technologies.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

May 1, 2014

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Allergy Therapeutics' Worthing Facility Receives Certificate of GMP Compliance

April 30, 2014

Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.

Gallus BioPharmaceuticals Uses ambr15 Micro Bioreactor to Develop Novel Antibodies and Biosimilars

April 30, 2014

TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.

Sartorius Stedim Biotech Acquires Majority Stake in AllPure Technologies

April 28, 2014

Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.

GE Healthcare and Promosome Sign Licensing Agreement

April 28, 2014

GE Healthcare and Promosome sign a licensing agreement that gives GE Healthcare exclusive rights to a new suite of mammalian cell line development technologies.

ADVERTISEMENT

ADVERTISEMENT

Click here